Pew, Wellcome, ASM Underscore Urgent Need to Reinvigorate Antibiotic Pipeline

Pew, Wellcome, ASM Underscore Urgent Need to Reinvigorate Antibiotic Pipeline

On June 16, 2016, The Pew Charitable Trusts, Wellcome, and the American Society for Microbiology convened a group of leading experts to explore potential next steps for advancing antibiotic discovery. After the meeting, the three organizations issued a joint statement affirming that the antibiotic pipeline is insufficient to meet current and future public health needs, and calling for a targeted effort to overcome scientific barriers to antibiotic discovery before it is too late.

National Homeownership Month

Article

37 Researchers Working to Transform Biomedical Science

Quick View
Article

Biomedical researchers are on the front lines of scientific innovation. From responding to global pandemics to pioneering lifesaving cancer treatments, these researchers push past scientific boundaries to solve pressing health challenges. For nearly 40 years, The Pew Charitable Trusts has supported more than 1,000 early-career biomedical scientists committed to this discovery.

Report

A Scientific Roadmap for Antibiotics

A sustained and robust pipeline of new antibacterial drugs and therapies is critical to preserve public health

Quick View
Report

In recent decades, the discovery and development of new antibiotics have slowed dramatically as scientific barriers to drug discovery, regulatory challenges, and diminishing returns on investment have led major drug companies to scale back or abandon their antibiotic research.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.